Sports participation for athletes with implantable cardioverter-defibrillators should be an individualized risk-benefit decision

Heart Rhythm

Volumn 5, Issue 6, 2008, Pages 861-863

  Lampert, Rachel ^a   Cannom, David ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Athlete; Implantable cardioverter defibrillator

Indexed keywords

ADRENALIN; MORACIZINE;

ARTICLE; ATHLETE; BASKETBALL; BRUGADA SYNDROME; DEFIBRILLATION; DEFIBRILLATOR; EXERCISE; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPORT; SUDDEN DEATH; SYNCOPE;

BRUGADA SYNDROME; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; DECISION MAKING; DEFIBRILLATORS, IMPLANTABLE; HUMANS; LONG QT SYNDROME; MOTOR ACTIVITY; RISK ASSESSMENT; SPORTS;

EID: 44549088307     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.01.024     Document Type: Article

References (10)

1. Maron B.J., and Zipes D.P. 36th Bethesda Conference: Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 45 (2005) 1313-1375
2. Albert C.M., Mittleman M.A., Chae C.U., et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343 (2000) 1355-1361
3. Corrado D., Basso C., Rizzoli G., et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003) 1959-1963
4. Sousa J., Kou W., Calkins H., et al. Effect of epinephrine on the efficacy of the internal cardioverter-defibrillator. Am J Cardiol 69 (1992) 509-512
5. Venditti F.J., John R.M., Hull M.L., et al. Circadian variation in defibrillation energy requirements. Circulation 94 (1996) 1607-1612
6. Suddath W.O., Deychak Y., and Varghese P.J. Electrophysiologic basis by which epinephrine facilitates defibrillation after prolonged episodes of ventricular fibrillation. Ann Emerg Med 38 (2001) 201-206
7. Papaioannou G.I., and Kluger J. Ineffective ICD therapy due to excessive alcohol and exercise. Pacing Clin Electrophysiol 25 (2002) 1144-1145
8. Begley D.A., Mohiddin S.A., Tripodi D., et al. Efficacy of implantable cardioverter-defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 26 (2003) 1887-1896
9. Lampert R., Cannom D., and Olshansky B. Safety of sports participation in patients with implantable cardioverter-defibrillators: a survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol 17 (2006) 11-15
10. Ropeik D., and Gray G. Risk: A Practical Guide for Deciding What's Really Safe and What's Really Dangerous in the World Around You (2002), Houghton Mifflin, Boston